MedPath
NMPA Approval

Ropivacaine Mesylate for Injection

国药准字H20090271

June 26, 2024

Drug Information

注射用甲磺酸罗哌卡因

注射剂

119.2mg

化学药品

June 26, 2024

Company Information

Applicant Company

山西省大同经济技术开发区第一医药园区

Manufacturing Company

山西省大同经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用甲磺酸罗哌卡因 - NMPA 批准文号 | MedPath